Menière's disease and hydrochlorothiazide (Dichlotride)--a critical analysis of symptoms and therapeutic effects.
Menière's disease and hydrochlorothiazide (Dichlotride)--a critical analysis of symptoms and therapeutic effects.
复制标题
梅尼埃病和氢氯噻嗪(二氯噻嗪)——症状和治疗效果的批判性分析。
DOI:
10.3109/00016486709128769
复制
发表时间:
1967
影响因子:
1.4
通讯作者:
U. Lindblom
中科院分区:
文献类型:
--
作者:
I. Klockhoff;U. Lindblom
In 50 cases of Meniere's disease, a diuretic, Dichlotride® (hydrochlorothiazide), was administered orally with the object of reducing the electrolyte disturbance and endolymphatic hydrops that can be presumed to be of pathogenetic importance. A pilot study was made in 20 cases. No effect was noted in cases in which the disease was in a late stationary stage, with non-fluctuating hearing loss of the “flat loss” type. In cases in which the disease still had a bout-like or fluctuating course, an improvement was obtained in connexion with therapy, but the results were inconclusive, in view of the greatly varying spontaneous course. A second treatment series was therefore carried out, using the double-blind technique, in 30 cases of the fluctuating type. The prevalence and intensity of the symptoms were recorded monthly. The hearing was measured by tone audiometry, whereas tinnitus, vertigo and general condition were graded according to fixed scales. All symptoms, as well as the general condition, showed a hig...